Edition:
India

Denali Therapeutics Inc (DNLI.OQ)

DNLI.OQ on NASDAQ Stock Exchange Global Select Market

14.00USD
11:25pm IST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$14.00
Open
$13.92
Day's High
$14.00
Day's Low
$13.74
Volume
21,678
Avg. Vol
120,253
52-wk High
$25.50
52-wk Low
$13.65

Chart for

About

Denali Therapeutics Inc. is a biotechnology company. The Company is focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS) and others. The Company is developing a diversified portfolio of therapeuti... (more)

Overall

No Ratios Available.

Financials

BRIEF-Denali Therapeutics Reports Qtrly Net Loss Per Share $0.74

* DENALI THERAPEUTICS ANNOUNCES FIRST-IN-HUMAN DOSING OF ITS RIPK1 INHIBITOR CLINICAL PROGRAM AND THE APPOINTMENT OF PETER KLEIN TO BOARD OF DIRECTORS; REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

19 Mar 2018

BRIEF-Temasek Holdings Dissolves Share Stake In Marin Software, Takes Share Stake In Denali Therapeutics

* TEMASEK HOLDINGS (PRIVATE) LTD DISSOLVES SHARE STAKE IN MARIN SOFTWARE INC - SEC FILING

14 Feb 2018

BRIEF-Denali Therapeutics, Lonza Pharma & Biotech Announce Exclusive Partnership To Develop And Produce Biologic Medicines

* DENALI THERAPEUTICS AND LONZA PHARMA & BIOTECH ANNOUNCE EXCLUSIVE PARTNERSHIP TO DEVELOP AND PRODUCE BIOLOGIC MEDICINES

08 Feb 2018

Earnings vs. Estimates